A New Approach for Controlling the Release Rate of Pheniramine Aminosalicylate Via Solid Dispersion in Different Types of Eudragit
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 10 (4) , 649-666
- https://doi.org/10.3109/03639048409041413
Abstract
Co-precipitates of pheniramine aminosalicylate [antihistamine] in different types of Eudragit were prepared. IR spectra indicated the absence of molecular interaction between the drug and Eudragit. The effect of polymer type on the retardation of drug release rate was in the following order: Eudragit S 100 > Eudragit L 100 > Eudragit RSPM or Eudragit RS 100 > Eudragit RLPM or Eudragit RL 100. The concentration of the polymer in the system was a determining factor in controlling the release rate of the drug. As the concentration of the polymer in the system increased, the release rate of the drug decreased. Co-precipitates of the drug in different ratios of Eudragit blends were also prepared. The release rate of the drug decreased by decreasing the concentration of the permeable Eudragit RLPM or Eudragit RSPM in the system. The rapid release rate of the drug from the physical mixtures excluded their application in controlling drug release.This publication has 3 references indexed in Scilit:
- Pharmaceutical Applications of Solid Dispersion SystemsJournal of Pharmaceutical Sciences, 1971
- Molecular-Scale Drug Entrapment as a Precise Method of Controlled Drug Release I: Entrapment of Cationic Drugs by Polymeric FlocculationJournal of Pharmaceutical Sciences, 1970
- Die „Zerfallsprüfung”︁ einzeldosierter oraler Arzneiformen mit verlängerter Wirkung in vitroArchiv der Pharmazie, 1960